Ginsenoside F2
Product Specifications
CAS Number
62025-49-4
Target
Endogenous Metabolite|||Apoptosis|||Autophagy
Related Pathways
Apoptosis|||Metabolism|||Autophagy
Purity
0.993
Bioactivity
Ginsenoside F2 has antiproliferative activity against breast cancer stem cells (CSCs) . It induces apoptosis in breast CSCs by activating the intrinsic apoptotic pathway and mitochondrial dysfunction.
Smiles
[H][C@@]1(CC[C@]2(C)[C@]1([H])[C@H](O)C[C@]1([H])[C@@]3(C)CC[C@H](O[C@]4([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@]3([H])CC[C@@]21C)[C@](C)(CCC=C(C)C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
Molecular Formula
C42H72O13
Molecular Weight
785.01
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
043079-ML490 100 µL
TNFRSF25, ID (TNFRSF25, APO3, DDR3, DR3, TNFRSF12, WSL, WSL1, Tumor necrosis factor receptor superfamily member 25, Apo-3, Apoptosis-inducing receptor AIR, Apoptosis-mediating receptor DR3, Apoptosis-mediating receptor TRAMP, Death receptor 3, Lymphocyte-associated receptor of death, Protein WSL, Protein WSL-1) (MaxLight 490) discontinued
Ask
View Details 
